InSilico Medicine Cayman TopCo

HK$37.46As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3696Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$21.57B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$44
17.63%
101.73%
Buy 12|0|5|11|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.69
0.71
0.72
0.72
16.41%
12.83%
7.79%
4.73%
Revenue$B
1.069
1.083
1.139
1.118
9.46%
7.48%
7.08%
2.39%
Peers (US$2.752B)
Cap (US$)
PE
2.865B
—
2.756B
259.4x
Capital
TTM
5Y
10Y
Leveragex
2.189
1.244
0.807
EBIT/Intx
1.089
0.076
0.094
Own earn%
(45.22)
101.15
76.64
Sh yield%
54.63
50.16
50.67
Owners
Insiders/Inst%
3.47
46.14
Short interest%
4.59
SBC / revenue%
4.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
18–23
$1 testx
−0.1
Incr. ROIC%
6